Iain D. Dukes - Net Worth and Insider Trading
Iain D. Dukes Net Worth
The estimated net worth of Iain D. Dukes is at least $225,280 dollars as of 2024-05-19. Iain D. Dukes is the Director of Iovance Biotherapeutics Inc and owns about 22,000 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $225,280. Details can be seen in Iain D. Dukes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Iain D. Dukes has not made any transactions after 2022-11-23 and currently still holds the listed stock(s).
Transaction Summary of Iain D. Dukes
Iain D. Dukes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Iain D. Dukes owns 3 companies in total, including Iovance Biotherapeutics Inc (IOVA) , Theseus Pharmaceuticals Inc (THRX) , and Ikena Oncology Inc (IKNA) .
Click here to see the complete history of Iain D. Dukes’s form 4 insider trades.
Insider Ownership Summary of Iain D. Dukes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-11-23 | director |
| THRX | Theseus Pharmaceuticals Inc | 2021-10-06 | director & other: Chairman |
| IKNA | Ikena Oncology Inc | 2021-03-25 | director |
Iain D. Dukes Latest Holdings Summary
Iain D. Dukes currently owns a total of 1 stock. Iain D. Dukes owns 22,000 shares of Iovance Biotherapeutics Inc (IOVA) as of November 23, 2022, with a value of $225,280.
Latest Holdings of Iain D. Dukes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2022-11-23 | 22,000 | 10.24 | 225,280 |
Holding Weightings of Iain D. Dukes
Iain D. Dukes Form 4 Trading Tracker
According to the SEC Form 4 filings, Iain D. Dukes has made a total of 1 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Iovance Biotherapeutics Inc is the acquisition of 10,000 shares on November 23, 2022, which cost Iain D. Dukes around $61,000.
Insider Trading History of Iain D. Dukes
- 1
Iain D. Dukes Trading Performance
GuruFocus tracks the stock performance after each of Iain D. Dukes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Iain D. Dukes is 18.18%. GuruFocus also compares Iain D. Dukes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Iain D. Dukes within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Iain D. Dukes's insider trading performs compared to the benchmark.
Performance of Iain D. Dukes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.71 | | | | | |
| Relative Return to S&P 500(%) | 3.53 | | | | | |
Iain D. Dukes Ownership Network
Iain D. Dukes Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Iain D. Dukes is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Iain D. Dukes made 1 insider transaction in Iovance Biotherapeutics Inc (IOVA) with a net purchase of 10,000. Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 290,000 shares made by Merrill A Mcpeak , a net purchase of 20,000,000 shares made by Wayne P. Rothbaum , and a net purchase of 1,000 shares made by Frederick G Vogt .
In summary, during the past 3 months, insiders sold 0 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 5,250,000 shares, with a net purchase of 5,250,000 shares. During the past 18 months, 0 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 20,301,000 shares were bought by its insiders, resulting in a net purchase of 20,301,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
Iain D. Dukes Mailing Address
Above is the net worth, insider trading, and ownership report for Iain D. Dukes. You might contact Iain D. Dukes via mailing address: 112 W. 34th Street, 17th Floor, New York Ny 10120.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
